Cargando…
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
Multidrug resistance (MDR), which significantly decreases the efficacy of anticancer drugs and causes tumor recurrence, has been a major challenge in clinical cancer treatment with chemotherapeutic drugs for decades. Several mechanisms of overcoming drug resistance have been postulated. Well known P...
Autores principales: | Xue, Xue, Liang, Xing-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777470/ https://www.ncbi.nlm.nih.gov/pubmed/22237039 http://dx.doi.org/10.5732/cjc.011.10326 |
Ejemplares similares
-
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
por: Zhang, Meng, et al.
Publicado: (2017) -
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
por: Mir, Suhail Ahmad, et al.
Publicado: (2022) -
State of the art of overcoming efflux transporter mediated multidrug resistance of breast cancer
por: Huang, Qingqing, et al.
Publicado: (2019) -
Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance
por: Li, Rui, et al.
Publicado: (2021) -
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
por: Yadav, Priya, et al.
Publicado: (2022)